Näringsliv - Newsroom - Medicinsk utrustning
Nyheter - Medicinsk utrustning
07/12/2009
New lists for Directives 90/385/EEC AIMDD, 93/42/EEC MDD and 98/79/EC IVDMD
13/10/2009
Between September 2009 and February 2010 the European Commission is hosting a series of 5 multistakeholder workshops on company disclosure of environmental, social and governance (ESG) information.
These workshops are part of the European Commission’s policy to promote corporate social responsibility.
Corporate Social Responsibility, also known as "CSR" is “a concept whereby enterprises integrate social and environmental issues into their business operations and into their relations with stakeholders on a voluntary basis” .
Filer att ladda ner
-
Workshop 1 - Summary of discussions
(202 Kb) -
ESG disclosure workshops - concept note 091014.pdf (88 Kb)
-
Presentation by Roger Cowe, Context
(8,7 Mb) -
Presentation by Joaquim Croca, Vodafone (443 Kb)
-
Presentation by Pierre Dutrieu & Yann Louvel (6,8 Mb)
-
Presentation by Bruno Prior, Summerleaze (134 Kb)
-
Presentation by Akira Fujiyoshi, Esai Co. Ltd (1,4 Mb)
-
Background document : Survey of quality of sustainability reports 2008 - Ernst and Young (292 Kb)
-
Background document : Statement and Guidance on Non-Financial Reporting - International Corporate Governance Network (128 Kb)
-
Background document : Reporting on CSR - introduction for supervisory and executive boards - Denmark government (630 Kb)
-
Background document : KPIs for ESG - European Federation of Financial Analysts Societies (1,1 Mb)
-
Background document : CSR in Annual Reports of Spanish Companies - Observatorio de Responsabilidad Corporativa (3,9 Mb)
-
Background document : Valuing non-financial performance (3,3 Mb)
-
Background document : XBRL the medium is the message (Ralf Frank) (81 Kb)
29/09/2009
Following the positive scientific opinion issued by the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMEA) on 24 September, yesterday the European Commission granted variations to two existing authorisations for vaccines for influenza pandemic (H1N1) 2009. The products concerned are Focetria® (Novartis), and Pandemrix® (GlaxoSmithKline). The vaccines will be authorised for use in all Member States of the EU and the EEA (Iceland, Liechtenstein and Norway). That should ensure that sufficient vaccines will be available before the start of the flu season and will reduce the risks for illnesses and deaths for European Citizens.
03/09/2009
Guidance on how to apply the provisions of the Regulation on classification, labelling and packaging of substances and mixtures (CLP) has been published on the ECHA website, including the Introductory Guidance on the CLP Regulation and the Guidance on the Application of the CLP Criteria.
| första | föregående | [1] 2 3 4 5 6 7 8 9 ... nästa | sista | Sida 1 av 20 (träffarna 1 till 4 av 79) |